Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Prime Medicine (PRME) Net Margin (2024 - 2025)

Prime Medicine (PRME) has disclosed Net Margin for 2 consecutive years, with 5498.69% as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Net Margin fell 356209.0% year-over-year to 5498.69%, compared with a TTM value of 4342.44% through Dec 2025, up 222417.0%, and an annual FY2025 reading of 4342.44%, up 222417.0% over the prior year.
  • Net Margin was 5498.69% for Q4 2025 at Prime Medicine, down from 4129.14% in the prior quarter.
  • Across five years, Net Margin topped out at 1936.6% in Q4 2024 and bottomed at 25128.23% in Q3 2024.